Jiang et al. demonstrated that cotreatment with leflunomide or its active metabolite teriflunomide with PA could enhance NO production, p-eNOS, and p-AMPKα by inhibition of dihydroorotate dehydrogenase (DHODH) to ameliorate endothelial dysfunction. Here, NOS3 is linked to endothelial dysfunction.